New CE Lesson: Overview of the American Diabetes Association's 2024 Standards of Care

U.S. Pharmacist sent this email to their subscribers on November 29, 2024.

If you are having trouble viewing this message, please click here, or go to https://www.uspharmacist.com/email/USP2474/USP2474.html to view.

November 2024 CE Available Now

Overview of the American Diabetes
Association’s 2024 Standards of Care

Faculty:

Yvette C. Terrie, BS Pharm, RPh
Clinical Pharmacist/Freelance Medical Writer
Haymarket, Virginia

Accreditation Statement:

Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0430-0000-24-116-H01-P
Credits: 2.0 hours (0.20 CEU)
Type of Activity: Knowledge
Published: November 1, 2024
Expires: November 30, 2026

Media: Internet
Fee: Payment of $7.95 required
Target Audience: Pharmacists
Estimated Time to Complete Activity: 120 minutes (2 hours)

Goal: To familiarize pharmacists with current American Diabetes Association recommendations for managing and preventing diabetes.

Objectives: After completing this activity, the participant should be able to:
1.	Describe the incidence, prevalence, risk factors, and complications of diabetes.
2.	Discuss the 2024 ADA Standards of Care guidelines for diagnosing, classifying, preventing, and treating diabetes and prediabetes.
3.	Explain the pharmacist’s role in diabetes management.
4.	Restate evidence-based data demonstrating the beneficial effects of pharmacist involvement in diabetes care, patient-centered treatment plans, and patient education.

Procedures: Complete the exam and evaluation at https://journalce.powerpak.com. Upon passing (score of 70% or higher), you can print or view your statement of credit immediately. If you receive a score lower than 70%, you will get a message notifying you that you did not pass. You will have two opportunities to pass the exam. Please contact [email protected] with any questions.

eDIRECT is a service of Jobson Medical Information LLC

the publisher of U.S. Pharmacist, 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102.

To change your address, reply to this message and give us your old and new addresses.

Type "Change of Address: eDIRECT Newsletter" in the subject line.

Be sure to add [email protected] to your address book.

Click here if you do not want to receive future emails from eDIRECT.

Text-only version of this email

If you are having trouble viewing this message, please click here, or go to New CE Lesson: Overview of the American Diabetes Association's 2024 Standards of Care November 2024 CE Available Now Overview of the American Diabetes Association’s 2024 Standards of Care Faculty: Yvette C. Terrie, BS Pharm, RPh Clinical Pharmacist/Freelance Medical Writer Haymarket, Virginia Accreditation Statement: Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN: 0430-0000-24-116-H01-P Credits: 2.0 hours (0.20 CEU) Type of Activity: Knowledge Published: November 1, 2024 Expires: November 30, 2026 Media: Internet Fee: Payment of $7.95 required Target Audience: Pharmacists Estimated Time to Complete Activity: 120 minutes (2 hours) Goal: To familiarize pharmacists with current American Diabetes Association recommendations for managing and preventing diabetes. Objectives: After completing this activity, the participant should be able to: 1. Describe the incidence, prevalence, risk factors, and complications of diabetes. 2. Discuss the 2024 ADA Standards of Care guidelines for diagnosing, classifying, preventing, and treating diabetes and prediabetes. 3. Explain the pharmacist’s role in diabetes management. 4. Restate evidence-based data demonstrating the beneficial effects of pharmacist involvement in diabetes care, patient-centered treatment plans, and patient education. Procedures: Complete the exam and evaluation at print or view your statement of credit immediately. If you receive a score lower than 70%, you will get a message notifying you that you did not pass. You will have two opportunities to pass the exam. Please contact [email protected] with any questions. © 2024 Jobson Medical Information LLC eDIRECT is a service of Jobson Medical Information LLC the publisher of U.S. Pharmacist, 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. To change your address, reply to this message and give us your old and new addresses. Type "Change of Address: eDIRECT Newsletter" in the subject line. Be sure to add [email protected] to your address book. Click here if you do not want to receive future emails from eDIRECT.

Show all